Cargando…
Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention
BACKGROUND AND OBJECTIVES: Chloroquine/hydroxychloroquine has recently been the subject of intense debate regarding its potential antiviral activity against SARS-Cov-2, the etiologic agent of COVID-19. Some report possible curative effects; others do not. Therefore, the objective of this study was t...
Autores principales: | Tarek, Mohammad, Savarino, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418279/ https://www.ncbi.nlm.nih.gov/pubmed/32780273 http://dx.doi.org/10.1007/s13318-020-00640-6 |
Ejemplares similares
-
Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization
por: Thémans, Pauline, et al.
Publicado: (2020) -
Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19
por: Zahr, Noël, et al.
Publicado: (2021) -
Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?
por: Afra, TP, et al.
Publicado: (2020) -
Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
por: Babayeva, Mariana, et al.
Publicado: (2020) -
Hydroxychloroquine lung pharmacokinetics in critically ill patients with COVID-19
por: Ruiz, S., et al.
Publicado: (2021)